Blue Bird’s (NASDAQ:BLBD) Q2 CY2026: Beats On Revenue

Blue Bird (NASDAQ:BLBD) reported Q2 CY2026 revenue of $517.2 million, up 29.9% year over year and 3.8% above Wall Street estimates, according to the company. Non-GAAP adjusted EPS was $1.28, up from $1.19 but 1.6% below consensus. The company guided full-year revenue to about $1.75 billion and expected EPS growth to $5.28.

Original reporting
Published Aug 5, 2026, 9:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 5, 2026, 9:44 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Blue Bird’s (NASDAQ:BLBD) Q2 CY2026: Beats On Revenue — source image
Decision brief

The 30-second read

$BLBDNeutralMed
01

Why it matters

The key trade inputs are the Q2 revenue beat (+29.9% YoY), adjusted EPS of $1.28 (slightly below consensus), operating margin at 12.1% (stable), and full-year revenue guidance around $1.75B with EPS expected to rise to $5.28.

02

Market read

Traders can reassess near-term expectations using the disclosed Q2 beat/miss mix and the stated full-year revenue and EPS trajectory.

03

What to watch

Operating margin is described as stable this quarter, and full-year EBITDA guidance is only in line, which can matter more for valuation than a single-quarter revenue outperformance.

Relevance 8/10Novelty 7/10Timing: after-hours/earnings reaction day (published 2026-08-05 21:15 UTC)

Background

Blue Bird is a school bus and parts manufacturer, and the article summarizes its Q2 CY2026 results versus Wall Street expectations.

Company-level read

Ticker impact

$BLBDNeutralMedium confidence
Context

Blue Bird reported Q2 CY2026 revenue up 29.9% to $517.2M, topping estimates, while adjusted EPS was $1.28, slightly below consensus.

Expected impact

Likely choppy trading around the earnings reaction, with upside bias if investors focus on revenue growth and margin stability.

Evidence & confidence

The article provides concrete Q2 revenue, EPS, operating margin, and forward revenue/EPS expectations, but it also flags an EPS miss and mixed guidance, limiting directional conviction.

Market effects

School bus demand and pricing power appear supportive, but margin stability rather than expansion may cap enthusiasm.

No specific regional demand or policy driver cited.

Limited, as the article is company-specific with no international supply or demand shocks mentioned.

Counterpoint

The revenue beat may be driven by price increases rather than unit growth, so the durability of the earnings power could be weaker than the top-line suggests.

Key entities

  • Blue Bird

    NASDAQ-listed school bus manufacturer reporting Q2 CY2026 results and full-year outlook.

  • Wall Street estimates

    Consensus benchmarks cited for revenue, EPS, and EBITDA expectations.

Related articles

$BLBDHigh

Blue Bird Corp (BLBD): Results of Operations and Financial Condition

Blue Bird Corp (BLBD) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 a2026q3resultsreleaseex991.htm EX-99.1 Document BLUE BIRD REPORTS FISCAL 2026 THIRD QUARTER RESULTS Net Sales of $517M and GAAP Net Income of $185M Adj. EBITDA of $71M with 14% Margin and 3,525 Buses Sold FY2026 Adj. EBITDA Guidance Raised MACON, Ga. (August 5, 2026) –

$BLBDMed

Blue Bird (BLBD) Stock Trades Up, Here Is Why

Blue Bird (BLBD) shares rose about 4% to $81.53 after Barclays raised its price target to $85 from $75 and kept an Overweight rating. Barclays cited updated machinery and construction forecasts, production trends, new awards, pricing, and acquisitions, plus Blue Bird’s cash generation and balance sheet. The stock hit an all-time high; analysts noted revenue declines and capacity limits.

$DTMedAI 8/10

Dynatrace Springs on Q1 Figures

Dynatrace (NYSE: DT) reported Q1 FY2027 results for the quarter ended June 30, 2026. Total ARR was $2,136 million, up 17%. Total revenue rose to $555 million, up 16%. Subscription revenue was $530 million. GAAP operating income was $71 million and non-GAAP $162 million. CEO Rick McConnell cited 41% organic net new ARR growth and accelerating TTM growth.

$DBXMed

Dropbox Shares Decline Despite Earnings Beat as Revenue Growth Disappoints

Dropbox (DBX) shares fell about 5% premarket to around $32.80 after Q2 2026 results. The company reported adjusted EPS of $0.75 vs $0.74 expected and revenue of $631.5M vs about $627M, but revenue rose only 0.9% year over year. Non-GAAP operating margin improved to 39.7%. Paying users reached 18.19M. William Blair upgraded to Market Perform, while consensus remains Sell.

$HLMedAI 8/10

Hecla Mining Q2 Earnings Call Highlights

Hecla Mining reported Q2 financial and operating updates. The company ended the quarter with $483 million cash, about $472 million net cash, and an essentially undrawn $225 million revolver. It projected 2026 free cash flow of about $500 million at $50 silver and $3,500 gold, and raised Greens Creek silver guidance to 8.0-8.3 million ounces. Production guidance was adjusted for Lucky Friday and Keno Hill.

$RCELHighAI 9/10

Avita Medical Shares Surge After Record Second-Quarter Performance

Avita Medical (NASDAQ:RCEL) shares rose about 21.7% in premarket after it reported record Q2 results. Revenue was $21.7M, up 18% YoY and about 8% above estimates. Adjusted loss per share narrowed to $0.25 vs $0.30 expected. Full-year 2026 revenue guidance raised to $86M-$89M and cash-flow breakeven targeted for Q4 2026. BTIG upgraded to Buy with a $7.00 target.